Category Research

FDA Grants Roche Breakthrough Device Designation for Blood Test Advancing Early Alzheimer’s Disease Detection

Roche (SIX: RO, ROG; OTCQX: RHHBY) disclosed today that its Elecsys pTau217 assay has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). Developed in collaboration with Eli Lilly and Company, this blood test aims to…

Read MoreFDA Grants Roche Breakthrough Device Designation for Blood Test Advancing Early Alzheimer’s Disease Detection

Orion Research Assistants Striving to Combat Cancer and Alleviate Pain: “Our Breakthrough Discovery Holds Promise for Shaping Future Research

Mira Leppänen-Mattelmäki, a Research Associate in Orion’s pain team, finds her greatest motivation in the potential impact their work may have on patients. For Minna Vuorenmaa, a Research Assistant in the cancer research team, the meaningfulness of aiding patients fuels…

Read MoreOrion Research Assistants Striving to Combat Cancer and Alleviate Pain: “Our Breakthrough Discovery Holds Promise for Shaping Future Research

Progress in Clinical Development of Efgartigimod for Primary Sjogren’s Disease by Argenx

A global immunology company dedicated to enhancing the lives of individuals grappling with severe autoimmune conditions has unveiled its intention to propel the development of efgartigimod into Phase 3 for adults diagnosed with primary Sjogren’s disease (SjD), following an in-depth…

Read MoreProgress in Clinical Development of Efgartigimod for Primary Sjogren’s Disease by Argenx

AbbVie’s Acquisition of Landos Biopharma Bolsters its Reach in Inflammatory and Autoimmune Conditions

AbbVie Inc. (NYSE: ABBV) (“AbbVie”) and Landos Biopharma, Inc. (NASDAQ: LABP) (“Landos”) have announced a definitive agreement today, wherein AbbVie will acquire Landos, a clinical stage biopharmaceutical company primarily focused on developing novel oral therapeutics for patients with autoimmune diseases.…

Read MoreAbbVie’s Acquisition of Landos Biopharma Bolsters its Reach in Inflammatory and Autoimmune Conditions

Comprehensive Research on the Global Covid-19 Diagnostic Market for 2024: Executive and Consultant Guides Available – ResearchAndMarkets.com

The “Global Covid-19 Diagnostic Market Forecast by Technology, Product, Channel and Country with Executive and Consultant Guides” report has been added to ResearchAndMarkets.com’s offering. Amidst signs of the pandemic easing, Covid-19 continues to reshape markets, especially in the realm of respiratory diagnostics, where a…

Read MoreComprehensive Research on the Global Covid-19 Diagnostic Market for 2024: Executive and Consultant Guides Available – ResearchAndMarkets.com

2024 Biopharma-Site Network Pulse Report: Insights from IQVIA, ICON, Parexel, Fortrea, PPD/Thermo Fisher, and Syneos Health – Research And Markets.com

The “2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report” has been added to ResearchAndMarkets.com’s offering. The landscape of biopharmaceutical clinical development is in a constant state of flux and progression. While major global Contract Research Organizations (CROs) cater to a significant portion…

Read More2024 Biopharma-Site Network Pulse Report: Insights from IQVIA, ICON, Parexel, Fortrea, PPD/Thermo Fisher, and Syneos Health – Research And Markets.com

Bio-Techne Attains European IVDR Certification for Diagnostic Test Monitoring Chronic Myeloid Leukemia

Bio-Techne Corporation (NASDAQ: TECH) has announced today that its Molecular Diagnostics Division, Asuragen, has successfully obtained Class C Certification under the new European Union In Vitro Diagnostic Regulation (IVDR) for its QuantideX® qPCR BCR-ABL IS Kit. This certification marks a…

Read MoreBio-Techne Attains European IVDR Certification for Diagnostic Test Monitoring Chronic Myeloid Leukemia

Labcorp Introduces pTau217 Blood Test for Faster Alzheimer’s Diagnosis and Clinical Trial Support

Labcorp, a leading provider of cutting-edge laboratory services, has unveiled its latest breakthrough: a test capable of detecting phosphorylated tau 217 (pTau217) in the blood. This innovative biomarker serves as a crucial tool in diagnosing Alzheimer’s disease and monitoring patients…

Read MoreLabcorp Introduces pTau217 Blood Test for Faster Alzheimer’s Diagnosis and Clinical Trial Support